MHTX — Manhattan Scientifics Share Price
0.000.00%
Last trade - 00:00- $0.95m
- $2.00m
Growth & Value
| 12m Forecast Rolling | Industry | Market | |
|---|---|---|---|
| PE Ratio (f) | n/a | ||
| PEG Ratio (f) | n/a | ||
| EPS Growth (f) | n/a | ||
| Dividend Yield (f) | n/a | ||
| Valuation (ttm) | Industry | Market | |
|---|---|---|---|
| Price to Book Value | n/a | ||
| Price to Tang. Book | n/a | ||
| Price to Free Cashflow | n/a | ||
| Price to Sales | n/a | ||
| EV to EBITDA | n/a | ||
Shareholder Activity
| Type | Buy / Hold / Sell |
|---|---|
| Institutions | |
| Directors | |
| Community |
Guru Screens
Quality
| Name | Industry | Market | |
|---|---|---|---|
| Return on Capital | n/a | ||
| Return on Equity | n/a | ||
| Operating Margin | n/a | ||
Financial Summary
| Year End 31st Dec | Unit | 2019 | 2020 | 2021 | 2022 | 2023 | 2024E | 2025E | CAGR / Avg |
|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | $m | 0.1 | 0.05 | 0.05 | 0.05 | n/a | n/a | n/a | n/a |
| Operating Profit | m | ||||||||
| Net Profit | m | ||||||||
| EPS Reported | |||||||||
| Diluted Normalised EPS | |||||||||
| EPS Growth | % | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| PE Ratio | x | ||||||||
| PEG | |||||||||
| Profitability | |||||||||
| Operating Margin | % | ||||||||
| ROA | % | ||||||||
| ROCE | % | ||||||||
| ROE | % | ||||||||
| Cashflow | |||||||||
| Op. Cashflow ps | |||||||||
| Capex ps | |||||||||
| Free Cashflow ps | |||||||||
| Dividends | |||||||||
| Dividend ps | |||||||||
| Dividend Growth | % | ||||||||
| Dividend Yield | % | ||||||||
| Dividend Cover | x | ||||||||
| Balance Sheet | |||||||||
| Cash etc | m | ||||||||
| Working Capital | m | ||||||||
| NFA | m | ||||||||
| Net Debt | m | ||||||||
| Book Value | m | ||||||||
| Diluted Weighted Average Shares | m | ||||||||
| Book Value ps | |||||||||
Other Ratios
| Leverage (ttm) | Total | - Intang | + Pension |
|---|---|---|---|
| Gross Gearing | |||
| Net Gearing | |||
| Cash / Assets |
| Liquidity (ttm) | |
|---|---|
| Curr. Ratio | |
| Quick Ratio | |
| Interest Cov. | |
| Efficiency (ttm) | |
|---|---|
| Asset Turnover | |
| Recs Turnover | |
| Stock Turnover | |
Recent History
| Latest interim period vs. prior period | Industry | Market | |
|---|---|---|---|
| Sales Growth | |||
| EPS Growth | |||
| 3yr Compound Annual Growth Rate | Industry | Market | |
|---|---|---|---|
| Sales CAGR | |||
| EPS CAGR | |||
| DPS CAGR | |||
Profile Summary
Manhattan Scientifics, Inc. is focused on technology transfer and commercialization of these transformative technologies. The Company operates as a technology incubator. Its business model is to identify significant technologies; acquire them or the rights to them; secure the services of inventors, engineers or other staff who were instrumental in their creation; provide or contract for suitable work facilities, laboratories, and other aids where appropriate; prototype the technologies to demonstrate proof of principle feasibility; secure patent and or other intellectual property protection; secure early customers for product trials where feasible and appropriate; and commercialize through licenses, sales or cooperative efforts with other manufacturing and distribution firms. Its business model is based on licensing metals technology to metals manufacturers. Its technologies are in a development phase.
Directors
- Marvin Maslow CHM (77)
- Emmanuel Tsoupanarias PRE (62)
- Leonard Friedman SEC (78)
- Frank Georgiou IND (64)
- Last Annual
- December 31st, 2023
- Last Interim
- December 31st, 2023
- Incorporated
- August 1st, 1995
- Public Since
- May 24th, 2000
- No. of Shareholders
- 635
- No. of Employees
- 11
- Sector
- Biotechnology & Medical Research
- Industry
- Healthcare
- Exchange
- Pink Sheets on Nasdaq
- Shares in Issue
- 559,281,064
- Address
- 405 LEXINGTON AVENUE, NEW YORK, 10174
- Web
- http://www.mhtx.com/
- Phone
- +1 2125412405
- Contact
- Marvin Maslow
- Auditors
- Sadler, Gibb & Associates, LLC
Upcoming Events for MHTX
Q2 2024 Manhattan Scientifics Inc Earnings Release
Similar to MHTX
Acorda Therapeutics
Pink Sheets on Nasdaq
Actavia Life Sciences
Pink Sheets on Nasdaq
Acura Pharmaceuticals
Pink Sheets on Nasdaq
Adhera Therapeutics
Pink Sheets on Nasdaq
Ramoil Management
Pink Sheets on Nasdaq
FAQ
What is the Manhattan Scientifics share price?
As of Today at 19:14 UTC, shares in Manhattan Scientifics are trading at $0.00. This share price information is delayed by 15 minutes.
How has the Manhattan Scientifics share price performed this year?
Shares in Manhattan Scientifics last closed at $0.00 and the price had moved by -71.67% over the past 365 days. In terms of relative price strength the Manhattan Scientifics share price has underperformed the S&P500 Index by -75% over the past year.
What are the analyst and broker recommendations for Manhattan Scientifics?
There is no consensus recommendation for this security.
What is the Manhattan Scientifics dividend yield?
Manhattan Scientifics does not currently pay a dividend.
Does Manhattan Scientifics pay a dividend?
Manhattan Scientifics does not currently pay a dividend.
When does Manhattan Scientifics next pay dividends?
Manhattan Scientifics does not currently pay a dividend.
How do I buy Manhattan Scientifics shares?
To buy shares in Manhattan Scientifics you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
What is the market cap of Manhattan Scientifics?
As of the previous close price of $0.00, shares in Manhattan Scientifics had a market capitalisation of $0.95m.
Where are Manhattan Scientifics shares listed?
Here are the trading details for Manhattan Scientifics:
- Country of listing: United States
- Exchange: PNK
- Ticker Symbol: MHTX
What kind of share is Manhattan Scientifics?
Based on an overall assessment of its quality, value and momentum Manhattan Scientifics is currently classified as a Sucker Stock. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
Is there a Manhattan Scientifics share price forecast for 2024?
We could not find analyst target price data for this security.
What is the trend in the Manhattan Scientifics share price?
An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Manhattan Scientifics. Over the past six months, its share price has underperformed the S&P500 Index by -62.42%.
As of the last closing price of $0.00, shares in Manhattan Scientifics were trading -57.94% below their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
What is the Manhattan Scientifics PE Ratio?
The Manhattan Scientifics PE ratio based on its reported earnings over the past 12 months is null. The shares last closed at $0.00.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
Who are the key directors of Manhattan Scientifics?
Manhattan Scientifics' management team is headed by:
- Marvin Maslow - CHM
- Emmanuel Tsoupanarias - PRE
- Leonard Friedman - SEC
- Frank Georgiou - IND